Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014–2015 to 2016–2017 influenza seasons in Japan
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (6) , 449-457
Abstract
No abstract availableKeywords
Funding Information
- Shionogi
- Chugai Pharmaceutical
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 32 references indexed in Scilit:
- Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza PatientsInternational Journal of Pediatrics, 2012
- Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus InfectionAntimicrobial Agents and Chemotherapy, 2012
- Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2011
- Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk PatientsAntimicrobial Agents and Chemotherapy, 2011
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and BClinical Infectious Diseases, 2009
- The course of fever following influenza virus infection in children treated with oseltamivirJournal of Medical Virology, 2008
- Natural Course of Fever During Influenza Virus Infection in ChildrenClinical Pediatrics, 2007
- Bias reduction of maximum likelihood estimatesBiometrika, 1993